Dr. Martens (LON:DOCS) Insider Ije Nwokori Buys 232 Shares of Stock

Dr. Martens plc (LON:DOCS) insider Ije Nwokori bought 232 shares of the firm’s stock in a transaction on Tuesday, April 14th. The shares were bought at an average price of GBX 65 per share, with a total value of £150.80.

Ije Nwokori also recently made the following trade(s):

• On Wednesday, February 11th, Ije Nwokori bought 219 shares of Dr. Martens stock. The shares were bought at an average price of GBX 69 per share, with a total value of £151.11.

Dr. Martens Price Performance

Shares of DOCS opened at GBX 66.40 on Thursday. The firm has a market cap of £641.91 million, a PE ratio of 39.06, a P/E/G ratio of 6.40 and a beta of 0.24. The company has a current ratio of 2.18, a quick ratio of 1.13 and a debt-to-equity ratio of 120.66. The firm has a fifty day simple moving average of GBX 65.50 and a two-hundred day simple moving average of GBX 75.75. Dr. Martens plc has a 1-year low of GBX 49.53 and a 1-year high of GBX 100.87.

Wall Street Analysts Forecast Growth

DOCS has been the subject of a number of research reports. Berenberg Bank reiterated a “buy” rating on shares of Dr. Martens in a research note on Tuesday, January 27th. Royal Bank Of Canada restated a “sector perform” rating on shares of Dr. Martens in a research note on Tuesday, February 3rd. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Dr. Martens currently has an average rating of “Moderate Buy” and a consensus price target of GBX 6,000.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.